SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

BRIEF-Arvinas Inc - On June 4, Co And Subsidiary Entered Into Master In Vitro Diagnostics Agreement With Foundation Medicine

reuters.com · 06/09/2022 17:28
BRIEF-Arvinas Inc - On June 4, Co And Subsidiary Entered Into Master In Vitro Diagnostics Agreement With Foundation Medicine

- Arvinas Inc ARVN:

  • ARVINAS INC - ON JUNE 4, CO AND SUBSIDIARY ENTERED INTO A MASTER IN VITRO DIAGNOSTICS AGREEMENT WITH FOUNDATION MEDICINE

  • ARVINAS- DEAL FOR DEVELOPMENT, COMMERCIALIZATION OF FOUNDATION MEDICINE'S COMPANION IN VITRO DIAGNOSTIC ASSAYS FOR USE WITH CO'S THERAPEUTIC PRODUCTS

  • ARVINAS INC - PURSUANT TO DEAL, CO WILL PAY FOUNDATION MEDICINE SUCCESS-BASED MILESTONE PAYMENTS OF UP TO LOW TO MID TENS OF MILLIONS OF DOLLARS

  • ARVINAS INC - PURSUANT TO DEAL, CO WILL PAY FOUNDATION MEDICINE CERTAIN VALIDATION FEES PER SAMPLE AND RELATED PASS-THROUGH COSTS


Further company coverage: ARVN


((Reuters.Briefs@thomsonreuters.com;))